<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>13</volume><submitter>Koneshamoorthy A</submitter><funding>National Health and Medical Research Council</funding><pubmed_abstract>We present a case of an obese 22-year-old man with activating &lt;i>GCK&lt;/i> variant who had neonatal hypoglycemia, re-emerging with hypoglycemia later in life. We investigated him for asymptomatic hypoglycemia with a family history of hypoglycemia. Genetic testing yielded a novel &lt;i>GCK&lt;/i> missense class 3 variant that was subsequently found in his mother, sister and nephew and reclassified as a class 4 likely pathogenic variant. Glucokinase enables phosphorylation of glucose, the rate-limiting step of glycolysis in the liver and pancreatic β cells. It plays a crucial role in the regulation of insulin secretion. Inactivating variants in &lt;i>GCK&lt;/i> cause hyperglycemia and activating variants cause hypoglycemia. Spleen-preserving distal pancreatectomy revealed diffuse hyperplastic islets, nucl</pubmed_abstract><journal>Frontiers in endocrinology</journal><pagination>842937</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8969599</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Case Report: Hypoglycemia Due to a Novel Activating Glucokinase Variant in an Adult - a Molecular Approach.</pubmed_title><pmcid>PMC8969599</pmcid><pubmed_authors>Seniveratne-Epa D</pubmed_authors><pubmed_authors>Farrell S</pubmed_authors><pubmed_authors>Chin LK</pubmed_authors><pubmed_authors>Taylor S</pubmed_authors><pubmed_authors>Sachithanandan N</pubmed_authors><pubmed_authors>Koneshamoorthy A</pubmed_authors><pubmed_authors>Calder G</pubmed_authors><pubmed_authors>Sawyer M</pubmed_authors><pubmed_authors>MacIsaac RJ</pubmed_authors><pubmed_authors>Liu X</pubmed_authors><pubmed_authors>Mariana L</pubmed_authors><pubmed_authors>Thorn P</pubmed_authors><pubmed_authors>Zacharin M</pubmed_authors><pubmed_authors>Krishnamurthy B</pubmed_authors><pubmed_authors>Trainer A</pubmed_authors><pubmed_authors>Thomas HE</pubmed_authors><pubmed_authors>Tong J</pubmed_authors><pubmed_authors>Kay TWH</pubmed_authors><pubmed_authors>Loudovaris T</pubmed_authors><pubmed_authors>Lyu R</pubmed_authors><pubmed_authors>McCarthy D</pubmed_authors></additional><is_claimable>false</is_claimable><name>Case Report: Hypoglycemia Due to a Novel Activating Glucokinase Variant in an Adult - a Molecular Approach.</name><description>We present a case of an obese 22-year-old man with activating &lt;i>GCK&lt;/i> variant who had neonatal hypoglycemia, re-emerging with hypoglycemia later in life. We investigated him for asymptomatic hypoglycemia with a family history of hypoglycemia. Genetic testing yielded a novel &lt;i>GCK&lt;/i> missense class 3 variant that was subsequently found in his mother, sister and nephew and reclassified as a class 4 likely pathogenic variant. Glucokinase enables phosphorylation of glucose, the rate-limiting step of glycolysis in the liver and pancreatic β cells. It plays a crucial role in the regulation of insulin secretion. Inactivating variants in &lt;i>GCK&lt;/i> cause hyperglycemia and activating variants cause hypoglycemia. Spleen-preserving distal pancreatectomy revealed diffuse hyperplastic islets, nucl</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022</publication><modification>2026-04-08T18:07:14.832Z</modification><creation>2025-04-05T22:19:43.134Z</creation></dates><accession>S-EPMC8969599</accession><cross_references><pubmed>35370948</pubmed><doi>10.3389/fendo.2022.842937</doi></cross_references></HashMap>